Julia Lainster

In the rapidly advancing realm of synthetic biology, a remarkable innovation is capturing the attention of scientists and industry leaders alike: the potential to produce proteins outside the confines of living cells using synthetic transfer RNA (tRNA) arrays. This cutting-edge development,

Cancer research has taken a remarkable leap forward with a recent study published in Nature Communications by Cao et al., shedding light on a previously unknown molecular mechanism that fuels tumor growth and opens new avenues for therapy. This groundbreaking work reveals a unique interaction

Leukemia, a relentless cancer affecting blood-forming cells, has puzzled researchers for decades due to its numerous genetic mutations that somehow result in strikingly similar disease outcomes in patients across diverse cases. A groundbreaking study from Baylor College of Medicine, recently

As the clock ticks toward October 1, the U.S. healthcare system braces for a pivotal moment that could reshape access to vital services for millions of Medicare beneficiaries, with key virtual care programs like telehealth flexibilities and the Acute Hospital Care at Home (AHCAH) waivers facing

Glaucoma, a devastating eye condition that ranks as a leading cause of blindness and affects over 4 million people in the United States, often disproportionately burdens older adults and specific racial groups, revealing significant disparities in care. A groundbreaking study published on October 6

I'm thrilled to be speaking with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the complex world of drug development for rare diseases, with a

The landscape of healthcare in England has undergone a notable shift with the recent updates to the general practice (GP) contract, effective from October 1, mandating that all GP surgeries maintain online consultation tools during core hours from 8 a.m. to 6:30 p.m. for routine patient inquiries.

Imagine a silent contaminant lurking in the tap water of millions, undetected by taste or smell, yet capable of accumulating in the human body with potential health consequences that could impact generations. Per- and polyfluoroalkyl substances (PFAS), often called "forever chemicals" due to their

Lipid reprogramming has emerged as a critical frontier in understanding and treating clear cell renal cell carcinoma (ccRCC), the predominant subtype of kidney cancer that accounts for a significant portion of cases worldwide. This metabolic transformation, where tumor cells drastically alter how

What happens when a tumor outsmarts the very treatments designed to destroy it, turning a lifeline into a losing battle for countless patients? In the relentless fight against breast and ovarian cancers tied to BRCA2 deficiencies, a staggering reality emerges: chemotherapy often fails as tumors